These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 5408742)

  • 21. [Pincus's method of exchange transfusion in newborn infants].
    Iordanov G; Vulov V
    Akush Ginekol (Sofiia); 1965; 4(5):477-8. PubMed ID: 5894279
    [No Abstract]   [Full Text] [Related]  

  • 22. [Diagnostic and therapeutic possibilities in hemolytic disease of the newborn].
    Colucci G
    Friuli Med; 1965; 20(2):149-73. PubMed ID: 5892007
    [No Abstract]   [Full Text] [Related]  

  • 23. [On the treatment of hemolytic disease of the newborn].
    Novachev D
    Akush Ginekol (Sofiia); 1967; 6(2):145-53. PubMed ID: 5602692
    [No Abstract]   [Full Text] [Related]  

  • 24. [Intrauterine transfusion in severe hemolytic disease caused by Rh sensitization].
    Lampé L; Kelemen J; Komáromy B; Mihály G
    Orv Hetil; 1970 Nov; 111(44):2598+. PubMed ID: 5488133
    [No Abstract]   [Full Text] [Related]  

  • 25. [Evaluation of the effectiveness of exchange transfusion in hemolytic disease of the newborn in view of hematological and biochemical studies].
    Jasiewicz A
    Zentralbl Gynakol; 1971 Jan; 93(5):168-72. PubMed ID: 5103114
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical follow-up studies on late prognosis of Rh-related hemolytic disease of the newborn. VII. Indications for exchange transfusion in Rh-incompatibility].
    Schneeweiss B
    Padiatr Grenzgeb; 1970; 9(3):208-17. PubMed ID: 4997628
    [No Abstract]   [Full Text] [Related]  

  • 27. [Activity of certain blood serum enzymes in hemolytic disease of the newborn treated by exchange transfusion].
    Tabolin VA; Efimov MS; Uryvchikov GA; Volodin NN
    Vopr Okhr Materin Det; 1974; 19(7):28-31. PubMed ID: 4471734
    [No Abstract]   [Full Text] [Related]  

  • 28. [Behavior of fetal hemoglobin, fetal erythrocytes and bilirubin in exchange transfusion in newborn with hemolytic disease].
    Jasiewicz A
    Pediatr Pol; 1966 Oct; 41(10):1137-43. PubMed ID: 6009356
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hemolytic disease of newborn].
    Speilmann W
    Dtsch Med Wochenschr; 1975 Sep; 100(38):1918. PubMed ID: 1192959
    [No Abstract]   [Full Text] [Related]  

  • 30. [The immediate risks of exchange transfusion in the newborn, studied in a series of 1,811 infants].
    Huchet J; Pinon F; André R
    Transfusion (Paris); 1967; 10(2):203-11. PubMed ID: 6070702
    [No Abstract]   [Full Text] [Related]  

  • 31. [Detection and treatment of the hemolytic disease of the newborn. Our results].
    Lebeau JM; Huys J
    Bull Soc R Belge Gynecol Obstet; 1965; 35(5):415-21. PubMed ID: 5864256
    [No Abstract]   [Full Text] [Related]  

  • 32. [Myocardial infarct in newborn infants following exchange transfusion].
    Pennaforte F; Leroux N; Dupoux D; Pluot M
    Arch Fr Pediatr; 1973 Feb; 30(2):189-97. PubMed ID: 4736807
    [No Abstract]   [Full Text] [Related]  

  • 33. [Erythropoietic activity in newborn infants with maternal-fetal incompatibility in the ABO system treated with exchange transfusion. Use of the Ashby method in 14 cases].
    Stegagno G; Mencarini L; Orvieto G
    Minerva Pediatr; 1968 Oct; 20(41):2131-42. PubMed ID: 5754726
    [No Abstract]   [Full Text] [Related]  

  • 34. Current problems of hemolytic disease.
    Lucey JF
    Ann Ostet Ginecol Med Perinat; 1971 Sep; 92(9):588-91. PubMed ID: 5157256
    [No Abstract]   [Full Text] [Related]  

  • 35. [Problems of exchange transfusion involving newborn infants].
    Shimada N
    Sanfujinka No Jissai; 1970 Jun; 19(6):562-7. PubMed ID: 5468468
    [No Abstract]   [Full Text] [Related]  

  • 36. [Can a proper choise of a blood preparation for exchange transfusion have an effect on the circulatory function in newborn infants with blood incompatibility?].
    Bielińska W; Debiec B; Pawlak Z
    Pediatr Pol; 1968 Aug; 43(8):967-76. PubMed ID: 5749004
    [No Abstract]   [Full Text] [Related]  

  • 37. [Results of 2 years' treatment of perinatal hemolytic disease. Results and current problems].
    Streiff F; Peters A; Genetet B; Moulin M
    Nouv Rev Fr Hematol; 1965; 5(5):771-7. PubMed ID: 4221306
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of the most serious forms of hemolytic disease of the newborn].
    Cagliero L; Cattaneo G; Mondo F
    Minerva Pediatr; 1966 Jul; 18(21):1115-20. PubMed ID: 5950345
    [No Abstract]   [Full Text] [Related]  

  • 39. [A new therapeutic possibility in Rh-isoimmune hemolytic disease of the newborn. The use of Rh-positive blood based on the study of free anti-D antibody in the newborn infant. (Preliminary note)].
    Pataki L; Kaiser G; Virág I; Román F
    Orv Hetil; 1967 Feb; 108(8):352-4. PubMed ID: 6041608
    [No Abstract]   [Full Text] [Related]  

  • 40. [Modern pediatric treatment of the hemolytic disease of the newborn].
    Török J
    Orv Hetil; 1968 Sep; 109(37):2017-22. PubMed ID: 4181114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.